QY Research > レポート一覧 > 薬品及びサプリメント > 免疫蛍光アッセイ世界市場の発展状況と動向 2024-2030

免疫蛍光アッセイ世界市場の発展状況と動向 2024-2030

英文タイトル: Global Immunofluorescence Assays Market Insights, Forecast to 2030

免疫蛍光アッセイ世界市場の発展状況と動向 2024-2030
  • レポートID:278861
  • 発表時期:2024-04-25
  • 訪問回数:533
  • ページ数:110
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:136
  • レポートカテゴリ: 薬品及びサプリメント

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は免疫蛍光アッセイ市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは免疫蛍光アッセイの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の免疫蛍光アッセイ市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは免疫蛍光アッセイのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に免疫蛍光アッセイ市場を分類しています。本研究に含まれる主な企業は:Thermo Fisher、Inova Diagnostics、Bio-Rad、Abcam、PerkinELmer、Merck Millipore、Cell Signaling Technology、MEDIPAN GMBH、Sino Biological、Danaher、Vector Laboratories

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Antibodies
Kits and Reagents
Labeling Dyes

用途別の市場セグメント:
Clinical Research
Laboratory Diagnostics

レポートの詳細内容
世界の免疫蛍光アッセイ市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、免疫蛍光アッセイタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の免疫蛍光アッセイ収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の免疫蛍光アッセイ市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、免疫蛍光アッセイ市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

免疫蛍光アッセイのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:免疫蛍光アッセイのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:免疫蛍光アッセイの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3免疫蛍光アッセイ企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:免疫蛍光アッセイの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:免疫蛍光アッセイの主要企業の概要を提供し、製品の説明と仕様、免疫蛍光アッセイの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research.  Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
Market Analysis and Insights: Global Immunofluorescence Assays Market
The global Immunofluorescence Assays market is projected to grow from US$ 1751.3 million in 2024 to US$ 2196.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.
The US & Canada market for Immunofluorescence Assays is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Immunofluorescence Assays is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Immunofluorescence Assays is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Immunofluorescence Assays include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Immunofluorescence Assays is widely used in various fields, such as Clinical Research and Laboratory Diagnostics, etc. Clinical Research provides greatest supports to the Immunofluorescence Assays industry development. In 2023, global % revenue of Immunofluorescence Assays went into Clinical Research filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Immunofluorescence Assays market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Immunofluorescence Assays, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Immunofluorescence Assays, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunofluorescence Assays revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Immunofluorescence Assays market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Immunofluorescence Assays revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc.

Market Segmentation
By Company
    Thermo Fisher
    Inova Diagnostics
    Bio-Rad
    Abcam
    PerkinELmer
    Merck Millipore
    Cell Signaling Technology
    MEDIPAN GMBH
    Sino Biological
    Danaher
    Vector Laboratories

Segment by Type
    Antibodies
    Kits and Reagents
    Labeling Dyes

Segment by Application
    Clinical Research
    Laboratory Diagnostics

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Immunofluorescence Assays in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immunofluorescence Assays companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunofluorescence Assays revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunofluorescence Assays Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Antibodies
1.2.3 Kits and Reagents
1.2.4 Labeling Dyes
1.3 Market by Application
1.3.1 Global Immunofluorescence Assays Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Clinical Research
1.3.3 Laboratory Diagnostics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Immunofluorescence Assays Market Perspective (2019-2030)
2.2 Global Immunofluorescence Assays Growth Trends by Region
2.2.1 Immunofluorescence Assays Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Immunofluorescence Assays Historic Market Size by Region (2019-2024)
2.2.3 Immunofluorescence Assays Forecasted Market Size by Region (2025-2030)
2.3 Immunofluorescence Assays Market Dynamics
2.3.1 Immunofluorescence Assays Industry Trends
2.3.2 Immunofluorescence Assays Market Drivers
2.3.3 Immunofluorescence Assays Market Challenges
2.3.4 Immunofluorescence Assays Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Immunofluorescence Assays by Players
3.1.1 Global Immunofluorescence Assays Revenue by Players (2019-2024)
3.1.2 Global Immunofluorescence Assays Revenue Market Share by Players (2019-2024)
3.2 Global Immunofluorescence Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Immunofluorescence Assays, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Immunofluorescence Assays Market Concentration Ratio
3.4.1 Global Immunofluorescence Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunofluorescence Assays Revenue in 2023
3.5 Global Key Players of Immunofluorescence Assays Head office and Area Served
3.6 Global Key Players of Immunofluorescence Assays, Product and Application
3.7 Global Key Players of Immunofluorescence Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Immunofluorescence Assays Breakdown Data by Type
4.1 Global Immunofluorescence Assays Historic Market Size by Type (2019-2024)
4.2 Global Immunofluorescence Assays Forecasted Market Size by Type (2025-2030)

5 Immunofluorescence Assays Breakdown Data by Application
5.1 Global Immunofluorescence Assays Historic Market Size by Application (2019-2024)
5.2 Global Immunofluorescence Assays Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Immunofluorescence Assays Market Size (2019-2030)
6.2 North America Immunofluorescence Assays Market Size by Type
6.2.1 North America Immunofluorescence Assays Market Size by Type (2019-2024)
6.2.2 North America Immunofluorescence Assays Market Size by Type (2025-2030)
6.2.3 North America Immunofluorescence Assays Market Share by Type (2019-2030)
6.3 North America Immunofluorescence Assays Market Size by Application
6.3.1 North America Immunofluorescence Assays Market Size by Application (2019-2024)
6.3.2 North America Immunofluorescence Assays Market Size by Application (2025-2030)
6.3.3 North America Immunofluorescence Assays Market Share by Application (2019-2030)
6.4 North America Immunofluorescence Assays Market Size by Country
6.4.1 North America Immunofluorescence Assays Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Immunofluorescence Assays Market Size by Country (2019-2024)
6.4.3 North America Immunofluorescence Assays Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Immunofluorescence Assays Market Size (2019-2030)
7.2 Europe Immunofluorescence Assays Market Size by Type
7.2.1 Europe Immunofluorescence Assays Market Size by Type (2019-2024)
7.2.2 Europe Immunofluorescence Assays Market Size by Type (2025-2030)
7.2.3 Europe Immunofluorescence Assays Market Share by Type (2019-2030)
7.3 Europe Immunofluorescence Assays Market Size by Application
7.3.1 Europe Immunofluorescence Assays Market Size by Application (2019-2024)
7.3.2 Europe Immunofluorescence Assays Market Size by Application (2025-2030)
7.3.3 Europe Immunofluorescence Assays Market Share by Application (2019-2030)
7.4 Europe Immunofluorescence Assays Market Size by Country
7.4.1 Europe Immunofluorescence Assays Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Immunofluorescence Assays Market Size by Country (2019-2024)
7.4.3 Europe Immunofluorescence Assays Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Immunofluorescence Assays Market Size (2019-2030)
8.2 China Immunofluorescence Assays Market Size by Type
8.2.1 China Immunofluorescence Assays Market Size by Type (2019-2024)
8.2.2 China Immunofluorescence Assays Market Size by Type (2025-2030)
8.2.3 China Immunofluorescence Assays Market Share by Type (2019-2030)
8.3 China Immunofluorescence Assays Market Size by Application
8.3.1 China Immunofluorescence Assays Market Size by Application (2019-2024)
8.3.2 China Immunofluorescence Assays Market Size by Application (2025-2030)
8.3.3 China Immunofluorescence Assays Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Immunofluorescence Assays Market Size (2019-2030)
9.2 Asia Immunofluorescence Assays Market Size by Type
9.2.1 Asia Immunofluorescence Assays Market Size by Type (2019-2024)
9.2.2 Asia Immunofluorescence Assays Market Size by Type (2025-2030)
9.2.3 Asia Immunofluorescence Assays Market Share by Type (2019-2030)
9.3 Asia Immunofluorescence Assays Market Size by Application
9.3.1 Asia Immunofluorescence Assays Market Size by Application (2019-2024)
9.3.2 Asia Immunofluorescence Assays Market Size by Application (2025-2030)
9.3.3 Asia Immunofluorescence Assays Market Share by Application (2019-2030)
9.4 Asia Immunofluorescence Assays Market Size by Region
9.4.1 Asia Immunofluorescence Assays Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Immunofluorescence Assays Market Size by Region (2019-2024)
9.4.3 Asia Immunofluorescence Assays Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Type
10.2.1 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Immunofluorescence Assays Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Application
10.3.1 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Immunofluorescence Assays Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Country
10.4.1 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Immunofluorescence Assays Introduction
11.1.4 Thermo Fisher Revenue in Immunofluorescence Assays Business (2019-2024)
11.1.5 Thermo Fisher Recent Developments
11.2 Inova Diagnostics
11.2.1 Inova Diagnostics Company Details
11.2.2 Inova Diagnostics Business Overview
11.2.3 Inova Diagnostics Immunofluorescence Assays Introduction
11.2.4 Inova Diagnostics Revenue in Immunofluorescence Assays Business (2019-2024)
11.2.5 Inova Diagnostics Recent Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Immunofluorescence Assays Introduction
11.3.4 Bio-Rad Revenue in Immunofluorescence Assays Business (2019-2024)
11.3.5 Bio-Rad Recent Developments
11.4 Abcam
11.4.1 Abcam Company Details
11.4.2 Abcam Business Overview
11.4.3 Abcam Immunofluorescence Assays Introduction
11.4.4 Abcam Revenue in Immunofluorescence Assays Business (2019-2024)
11.4.5 Abcam Recent Developments
11.5 PerkinELmer
11.5.1 PerkinELmer Company Details
11.5.2 PerkinELmer Business Overview
11.5.3 PerkinELmer Immunofluorescence Assays Introduction
11.5.4 PerkinELmer Revenue in Immunofluorescence Assays Business (2019-2024)
11.5.5 PerkinELmer Recent Developments
11.6 Merck Millipore
11.6.1 Merck Millipore Company Details
11.6.2 Merck Millipore Business Overview
11.6.3 Merck Millipore Immunofluorescence Assays Introduction
11.6.4 Merck Millipore Revenue in Immunofluorescence Assays Business (2019-2024)
11.6.5 Merck Millipore Recent Developments
11.7 Cell Signaling Technology
11.7.1 Cell Signaling Technology Company Details
11.7.2 Cell Signaling Technology Business Overview
11.7.3 Cell Signaling Technology Immunofluorescence Assays Introduction
11.7.4 Cell Signaling Technology Revenue in Immunofluorescence Assays Business (2019-2024)
11.7.5 Cell Signaling Technology Recent Developments
11.8 MEDIPAN GMBH
11.8.1 MEDIPAN GMBH Company Details
11.8.2 MEDIPAN GMBH Business Overview
11.8.3 MEDIPAN GMBH Immunofluorescence Assays Introduction
11.8.4 MEDIPAN GMBH Revenue in Immunofluorescence Assays Business (2019-2024)
11.8.5 MEDIPAN GMBH Recent Developments
11.9 Sino Biological
11.9.1 Sino Biological Company Details
11.9.2 Sino Biological Business Overview
11.9.3 Sino Biological Immunofluorescence Assays Introduction
11.9.4 Sino Biological Revenue in Immunofluorescence Assays Business (2019-2024)
11.9.5 Sino Biological Recent Developments
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher Immunofluorescence Assays Introduction
11.10.4 Danaher Revenue in Immunofluorescence Assays Business (2019-2024)
11.10.5 Danaher Recent Developments
11.11 Vector Laboratories
11.11.1 Vector Laboratories Company Details
11.11.2 Vector Laboratories Business Overview
11.11.3 Vector Laboratories Immunofluorescence Assays Introduction
11.11.4 Vector Laboratories Revenue in Immunofluorescence Assays Business (2019-2024)
11.11.5 Vector Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Immunofluorescence Assays Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Antibodies
    Table 3. Key Players of Kits and Reagents
    Table 4. Key Players of Labeling Dyes
    Table 5. Global Immunofluorescence Assays Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Immunofluorescence Assays Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Immunofluorescence Assays Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Immunofluorescence Assays Market Share by Region (2019-2024)
    Table 9. Global Immunofluorescence Assays Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Immunofluorescence Assays Market Share by Region (2025-2030)
    Table 11. Immunofluorescence Assays Market Trends
    Table 12. Immunofluorescence Assays Market Drivers
    Table 13. Immunofluorescence Assays Market Challenges
    Table 14. Immunofluorescence Assays Market Restraints
    Table 15. Global Immunofluorescence Assays Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Immunofluorescence Assays Revenue Share by Players (2019-2024)
    Table 17. Global Top Immunofluorescence Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunofluorescence Assays as of 2023)
    Table 18. Global Immunofluorescence Assays Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Immunofluorescence Assays Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Immunofluorescence Assays, Headquarters and Area Served
    Table 21. Global Key Players of Immunofluorescence Assays, Product and Application
    Table 22. Global Key Players of Immunofluorescence Assays, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Immunofluorescence Assays Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Immunofluorescence Assays Revenue Market Share by Type (2019-2024)
    Table 26. Global Immunofluorescence Assays Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Immunofluorescence Assays Revenue Market Share by Type (2025-2030)
    Table 28. Global Immunofluorescence Assays Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Immunofluorescence Assays Revenue Share by Application (2019-2024)
    Table 30. Global Immunofluorescence Assays Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Immunofluorescence Assays Revenue Share by Application (2025-2030)
    Table 32. North America Immunofluorescence Assays Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Immunofluorescence Assays Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Immunofluorescence Assays Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Immunofluorescence Assays Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Immunofluorescence Assays Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Immunofluorescence Assays Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Immunofluorescence Assays Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Immunofluorescence Assays Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Immunofluorescence Assays Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Immunofluorescence Assays Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Immunofluorescence Assays Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Immunofluorescence Assays Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Immunofluorescence Assays Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Immunofluorescence Assays Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Immunofluorescence Assays Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Immunofluorescence Assays Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Immunofluorescence Assays Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Immunofluorescence Assays Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Immunofluorescence Assays Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Immunofluorescence Assays Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Immunofluorescence Assays Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Immunofluorescence Assays Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Immunofluorescence Assays Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Immunofluorescence Assays Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Immunofluorescence Assays Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Immunofluorescence Assays Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Thermo Fisher Company Details
    Table 65. Thermo Fisher Business Overview
    Table 66. Thermo Fisher Immunofluorescence Assays Product
    Table 67. Thermo Fisher Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 68. Thermo Fisher Recent Developments
    Table 69. Inova Diagnostics Company Details
    Table 70. Inova Diagnostics Business Overview
    Table 71. Inova Diagnostics Immunofluorescence Assays Product
    Table 72. Inova Diagnostics Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 73. Inova Diagnostics Recent Developments
    Table 74. Bio-Rad Company Details
    Table 75. Bio-Rad Business Overview
    Table 76. Bio-Rad Immunofluorescence Assays Product
    Table 77. Bio-Rad Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 78. Bio-Rad Recent Developments
    Table 79. Abcam Company Details
    Table 80. Abcam Business Overview
    Table 81. Abcam Immunofluorescence Assays Product
    Table 82. Abcam Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 83. Abcam Recent Developments
    Table 84. PerkinELmer Company Details
    Table 85. PerkinELmer Business Overview
    Table 86. PerkinELmer Immunofluorescence Assays Product
    Table 87. PerkinELmer Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 88. PerkinELmer Recent Developments
    Table 89. Merck Millipore Company Details
    Table 90. Merck Millipore Business Overview
    Table 91. Merck Millipore Immunofluorescence Assays Product
    Table 92. Merck Millipore Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 93. Merck Millipore Recent Developments
    Table 94. Cell Signaling Technology Company Details
    Table 95. Cell Signaling Technology Business Overview
    Table 96. Cell Signaling Technology Immunofluorescence Assays Product
    Table 97. Cell Signaling Technology Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 98. Cell Signaling Technology Recent Developments
    Table 99. MEDIPAN GMBH Company Details
    Table 100. MEDIPAN GMBH Business Overview
    Table 101. MEDIPAN GMBH Immunofluorescence Assays Product
    Table 102. MEDIPAN GMBH Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 103. MEDIPAN GMBH Recent Developments
    Table 104. Sino Biological Company Details
    Table 105. Sino Biological Business Overview
    Table 106. Sino Biological Immunofluorescence Assays Product
    Table 107. Sino Biological Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 108. Sino Biological Recent Developments
    Table 109. Danaher Company Details
    Table 110. Danaher Business Overview
    Table 111. Danaher Immunofluorescence Assays Product
    Table 112. Danaher Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 113. Danaher Recent Developments
    Table 114. Vector Laboratories Company Details
    Table 115. Vector Laboratories Business Overview
    Table 116. Vector Laboratories Immunofluorescence Assays Product
    Table 117. Vector Laboratories Revenue in Immunofluorescence Assays Business (2019-2024) & (US$ Million)
    Table 118. Vector Laboratories Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Immunofluorescence Assays Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Immunofluorescence Assays Market Share by Type: 2023 VS 2030
    Figure 3. Antibodies Features
    Figure 4. Kits and Reagents Features
    Figure 5. Labeling Dyes Features
    Figure 6. Global Immunofluorescence Assays Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Immunofluorescence Assays Market Share by Application: 2023 VS 2030
    Figure 8. Clinical Research Case Studies
    Figure 9. Laboratory Diagnostics Case Studies
    Figure 10. Immunofluorescence Assays Report Years Considered
    Figure 11. Global Immunofluorescence Assays Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Immunofluorescence Assays Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Immunofluorescence Assays Market Share by Region: 2023 VS 2030
    Figure 14. Global Immunofluorescence Assays Market Share by Players in 2023
    Figure 15. Global Top Immunofluorescence Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunofluorescence Assays as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Immunofluorescence Assays Revenue in 2023
    Figure 17. North America Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Immunofluorescence Assays Market Share by Type (2019-2030)
    Figure 19. North America Immunofluorescence Assays Market Share by Application (2019-2030)
    Figure 20. North America Immunofluorescence Assays Market Share by Country (2019-2030)
    Figure 21. United States Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Immunofluorescence Assays Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Immunofluorescence Assays Market Share by Type (2019-2030)
    Figure 25. Europe Immunofluorescence Assays Market Share by Application (2019-2030)
    Figure 26. Europe Immunofluorescence Assays Market Share by Country (2019-2030)
    Figure 27. Germany Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Immunofluorescence Assays Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Immunofluorescence Assays Market Share by Type (2019-2030)
    Figure 35. China Immunofluorescence Assays Market Share by Application (2019-2030)
    Figure 36. Asia Immunofluorescence Assays Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Immunofluorescence Assays Market Share by Type (2019-2030)
    Figure 38. Asia Immunofluorescence Assays Market Share by Application (2019-2030)
    Figure 39. Asia Immunofluorescence Assays Market Share by Region (2019-2030)
    Figure 40. Japan Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Immunofluorescence Assays Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Immunofluorescence Assays Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Immunofluorescence Assays Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Immunofluorescence Assays Market Share by Country (2019-2030)
    Figure 50. Brazil Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Immunofluorescence Assays Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Thermo Fisher Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 57. Inova Diagnostics Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 58. Bio-Rad Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 59. Abcam Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 60. PerkinELmer Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 61. Merck Millipore Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 62. Cell Signaling Technology Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 63. MEDIPAN GMBH Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 64. Sino Biological Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 65. Danaher Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 66. Vector Laboratories Revenue Growth Rate in Immunofluorescence Assays Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)